Legal threats, opacity, and deceptive research practices: A look at more than 100 retractions in business and management

What can studying retractions in business and management journals tell us? Earlier this year, Dennis Tourish, of the University of Sussex, and Russell Craig, of the University of Portsmouth, both in the UK, published a paper in the Journal of Management Inquiry that analyzed 131 such retractions. The duo — who were also two of … Continue reading Legal threats, opacity, and deceptive research practices: A look at more than 100 retractions in business and management

Engineering prof in Italy earns 26 retractions in one fell swoop

Antonio Orlandi, a professor of electrical engineering at the University of L’Aquila, in Italy, has had 26 papers retracted from a single journal, on a single day. Orlandi’s retractions come with a twist: He was, until recently, the editor in chief of the journal where the articles appeared, IEEE Transactions on Electromagnetic Compatibility.

Weekend reads: A debate over journal editors; academic corruption in China; a poisoning in a lab

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured the retraction and replacement of a paper on whether gun … Continue reading Weekend reads: A debate over journal editors; academic corruption in China; a poisoning in a lab

Judge dismisses most of Carlo Croce’s libel case against the New York Times

Carlo Croce, a prolific cancer researcher at The Ohio State University in Columbus who was the subject of a front page story in The New York Times last year about allegations of misconduct against him, has had most of a lawsuit he filed against the newspaper thrown out. As first reported by Courthouse News Service, … Continue reading Judge dismisses most of Carlo Croce’s libel case against the New York Times

When is asparagus not asparagus? Why, when it’s ginger, of course!

Allow us to explain that headline. Food Science & Nutrition has retracted a 2018 article by a group of researchers in China and Pakistan for plagiarism. The article was titled “Experimentally investigated the asparagus (Asparagus officinalis L.) drying with flat-plate collector under the natural convection indirect solar dryer.”   Per the retraction notice:

Weekend reads: Our database of 18,000-plus retractions is launched; inside a trial gone wrong; scholarly publishers bow to censorship

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured the official launch of our database of more than 18,000 … Continue reading Weekend reads: Our database of 18,000-plus retractions is launched; inside a trial gone wrong; scholarly publishers bow to censorship

We’re officially launching our database today. Here’s what you need to know.

Readers, this is a big day for us. We’re officially launching the Retraction Watch Database of more than 18,000 retractions, along with a six-page package of stories and infographics based on it that we developed with our partners at Science Magazine. In that package, you’ll learn about trends — some surprising, some perhaps not — … Continue reading We’re officially launching our database today. Here’s what you need to know.

Retraction Watch Database User Guide Appendix B: Reasons

Reason Description Author Unresponsive Author(s) lack of communication after prior contact by Journal, Publisher or other original Authors Bias Issues or Lack of Balance Failure to maintain objectivity in the presentation or analysis of information Breach of Policy by Author A violation of the Journal, Publisher or Institutional accepted practices by the author Breach of … Continue reading Retraction Watch Database User Guide Appendix B: Reasons

As China cracks down on faked drug trial data, US FDA abandons disclosure rule

The FDA has walked away from a 2010 rule that would have forced drug makers to disclose fabricated data to regulators. As Bloomberg Law reported last week, the FDA has withdrawn the proposed rule, “Reporting Information Regarding Falsification of Data,” which would